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Ambulation measures are being increasingly recognized as highly relevant to the quantification of multiple 
sclerosis (MS) severity and response to treatment. Feet paths are highly informative for gait analysis and we 
have recently designed a new system, which captures the position of the feet in real time. We use several range 
laser scanners (RLS) to analyze a horizontal slice of the scene in which each foot is considered as a point, and 
the vertical movements are ignored. Neat ambulation measures may be easily extracted such as walking speed, 
distance between feet over time, swing phase duration, and gait asymmetry in specific settings of walking 
recommendations. Our RLS platform is much cheaper than existing sensor-based and motion capture systems 
and may be more convenient for the development of multicentric clinical trial settings since patients can be 
easily and rapidly assessed without tags or sensors in the hallway of an outpatient clinic. We use 4 BEA LZR-
i100 RLS arranged in a corridor of at least 10m long and 4m width, devoid of obstacle. The scanned plane is 
chosen to be located at 15 cm above the floor, which is right above the tibio-tarsal joint of the ankle in a barefoot 
configuration for adult individuals in stance phase.  
We expect further studies to validate and empower the meaning of non-intrusive RLS-derived gait measures that 
should pave the ground for major improvements in the way we will assess the efficacy of disease-modifying 
treatments (DMTs), physical therapy and symptomatic interventions on walking impairment, ataxia and 
fatigability in MS. RLS-derived gait measures may also reveal to be crucial in the near future for the 
development of treatments that would specifically target progressive forms of MS. 
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Human gait is remarkable. The healthy locomotor 
system integrates input from the motor cortex, 
cerebellum, and the basal ganglia, as well as 
feedback from visual, vestibular and proprioceptive 
sensors to produce carefully controlled motor 
commands that result in coordinated muscle firings 
and limb movements. When everything is working 
properly, this multi-level neural control system 
produces a stable gait and a highly consistent 
walking pattern. In fact, the kinetics, kinematics, 
and muscular activity of normal gait appear to 
remain relatively constant from one stride to the 
next, even during unconstrained walking. 
 
Multiple sclerosis (MS) is a chronic multifocal 
disease of the CNS, which produces a wide range 
of neurological deficits but ambulation impairment 
is recognized as a prominent feature of disability in 
MS, both by physicians and people with MS (pMS) 
(1). The mechanisms underlying gait impairment 
are obviously complex and partially elusive 
because the quantification of gait performances in 
MS used to remain limited to the simple anamnestic 
recall of the maximum reported walking distance 
(MrWD) (2), the manual stopwatch measurement of 
walking speed on short distance walking tests (3, 4) 
through various settings and methodologies (5-10), 
and the measurement of the maximum distance 
performed in a given time (11). In contrast to 
maximum walking distance, walking speed (WS) is 
believed to be a far more stable parameter, which is 
less day-to-day variable and can be extracted from 
various walking paradigms (12, 13). Only few 
studies have investigated the behavior of pMS’ 
performances on longer distance walking tests, with 
variable results and using exclusively manual 
stopwatch-based methodologies, as well as small 
population samples (11, 14, 15).  
 
RESULTS AND DISCUSSION 
 
Since gait is such a complex motor behavior, which 
can only be roughly disentangled by a single 
walking test, we previously hypothesized that a 
multimodal walking assessment of gait would allow 
a better delineation and quantification of the 
functional impairment, which is present early in 
MS before the Expanded Disability Status Score 
(EDSS) score has reached a value of 2.5 (6, 15). 
We have recently developed new outcome 
measures showing that the comparative assessment 
of WS on short and long distance may represent a 
feasible way to measure gait fatigability in pMS. 
We have compared head to head the Timed 25-Foot 
Walk Test (T25FW), a corrected version of the 
T25FW with a dynamic start (T25FW+), the Timed 
100-Meter Walk Test (T100MW), and the Timed 
500-Meter Walk Test (T500MW) according to the 
paradigm «as fast as possible» (15). We observed 
that deceleration during a long demanding walking 
task (T500MW) is a measurable parameter 
reflecting motor fatigue. Furthermore, we have 
compared the maximal walking speed on short 
distance with a static start (conventional T25FW) or 
with a dynamic start allowing a 3 meters run-up 
(T25FW+). This latter analysis has demonstrated 
that the maximum WS and the capacity of MS 
patients to accelerate on a specific distance may be 
independently regulated and assessed separately 
(10). Our refinement of ambulation measurement 
provides a greater sensitivity in detecting subtle and 
specific abnormalities, especially in patients where 
the level of disability remains low or unapparent. 
 
The most commonly used sensors devoted to 
capture gait are cameras (16-18), electronic 
walkways (such as the GAITRite (19)), and motion 
capture systems (e.g. CodaMotion units CX1 (20)). 
These systems have however significant drawbacks 
such as the lack of reliability of the information 
obtained with color cameras since it depends on 
lighting conditions. The GAITRite system is 
expensive and provides only information regarding 
the position of the feet in the stance phase. Motion 
capture systems are also expensive and require that 
the users wear (active or passive) tags, which is not 
possible in most applications. 
 
As feet paths are highly informative for gait 
analysis and recognition (21), we have recently 
designed a new system which captures the position 
of the feet in real time (22). We use several range 
laser scanners (RLS) to analyze a horizontal slice of 
the scene in which each foot is considered as a 
point, and the vertical movements are ignored. 
Useful information may be easily extracted such as 
walking speed, distance between feet over time, 
swing phase duration, and gait asymmetry in 
specific settings of walking recommendations (22). 
 
Our RLS platform is cheaper than existing motion 
capture systems and GAITRites, is insensitive to 
lighting conditions (22), measures stride kinetics 
through feet positions in both swing and stance 
phases, and will be convenient for the development 
of multicentric clinical trial settings since patients 
can be easily and rapidly assessed without tags or 
sensors in the hallway of an outpatient clinic. 
 
We are currently running a prospective, controlled 
and multicentric trial using 4 BEA LZR-i100 
(BEA, Belgium) RLS arranged in a corridor of at 
least 10m length and 4m width, devoid of obstacle 
(Fig. 1).  
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Figure 1. Schematics of the corridor. Our feet tracker is based on the distance profiles provided by the BEA 
RLS displayed on the right. 
 
The 4 RLS measure distances in 274 directions 
spanning 96°, in a plane, at 15Hz. The scanned 
plane was chosen to be located at 15 cm above the 
floor, which is right above the tibio-tarsal joint of 
the ankle in a barefoot configuration for adult 
individuals in stance phase. Using several sensors 
allows us to reduce occlusions and to cover a wider 
area. Two video cameras will simultaneously 
record the global silhouette and upper/lower part of 
the subject’s body during the walking tasks. 
 
Some demonstrative sequences recorded with the 
current version of this setup (February 2012) are 
available at the following URL: 
http://www.montefiore.ulg.ac.be/~pierard/vgaims/d
emos_chu_february_2012/. Each sequence is 
accompanied by a video and graphs showing 
various features of the gait computed automatically 
from the acquired data. The following information 
are easily extracted from any walking task: global 
walking speed, mean speed of each foot, mean 
distance covered by each foot per gait cycle, lateral 
distance between feet over time, mean and 
maximum deviation of each foot/body center of 
mass from midline/useful trajectory, swing/stance 
phase durations.  
 
The trial that we are currently running using RLS-
based technology will be the first controlled and 
prospective trial to investigate pMS through 
ambulation outcome measures which are 
susceptible to capture stride abnormalities, gait 
ataxia, gait symmetry and distance-induced motor 
fatigue and spasticity.  
 
We expect this trial to validate and empower the 
meaning of non-intrusive RLS-derived gait 
measures that should pave the ground for major 
improvements in the way we assess the efficacy of 
DMTs, physical therapy and symptomatic 
interventions on walking impairment, ataxia and 
fatigability in MS.  
 
RLS-derived gait measures may also reveal to be 
crucial in the near future for the development of 
treatments that would specifically target 
progressive forms of MS. 
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